The full content of Annals is available to subscribers

Subscribe/Learn More  >
In the Clinic |

Hepatitis C

Janice H. Jou, MD; and Andrew J. Muir, MD
Ann Intern Med. 2012;157(11):ITC6-1. doi:10.7326/0003-4819-157-11-201212040-01006
Text Size: A A A

The approach to hepatitis C virus (HCV) infection has undergone tremendous change in the past 2 years. The first-generation protease inhibitors have been approved for treatment of genotype 1 infection, leading to sustained virologic response (SVR) rates of 68%–75% for treatment-naïve patients (1, 2). Other direct-acting antiviral agents are being developed, and it is expected that treatments for all genotypes will have better response rates and side effect profiles in coming years. In this context, the Centers for Disease Control and Prevention (CDC) recently updated its HCV screening guidelines and now recommends screening for all Americans born between 1945 and 1965 (3) because the baby-boomer generation has the highest prevalence of HCV infection (4). Risks for cirrhosis and hepatocellular carcinoma continue to rise due to progression of HCV infection, and HCV remains the most common indication for liver transplantation. Effective treatment can reduce the risk for these life-threatening complications, and here we discuss HCV prevention, screening, diagnosis, and management (5).

First Page Preview

View Large
First page PDF preview


Grahic Jump Location
Figure 1.

Regimens for treatment-naïve hepatitis C genotype 1.

Grahic Jump Location
Grahic Jump Location
Figure 2.

Regimens for treatment-experienced hepatitis C genotype 1.

Grahic Jump Location




CME Activities are only available to ACP members and Individual Annals subscribers. If you are a member or a subscriber please sign in. Otherwise please become a member or subscribe to Annals.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $32.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Journal Club
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.